Healthcare Services

Cannabis use disorder market trends influencing growth

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Cannabis Use Disorder Market Between 2026 And 2030?

The cannabis use disorder market has experienced substantial expansion in recent years. Its value is projected to increase from $1.65 billion in 2025 to $1.78 billion in 2026, at a compound annual growth rate (CAGR) of 7.5%. This historical growth can be attributed to several factors including the rising prevalence of cannabis consumption, increased awareness of substance use disorders, the expansion of rehabilitation infrastructure, enhanced recognition of mental health disorders, and the establishment of behavioral therapy frameworks.

The cannabis use disorder market is projected to experience substantial expansion over the upcoming years. By 2030, this market is anticipated to reach a valuation of $2.35 billion, demonstrating a compound annual growth rate (CAGR) of 7.3%. Several factors will drive this growth during the forecast period, including the growing acceptance of digital mental health solutions, increased investments in addiction research, the broadening of telehealth-based treatment models, a heightened emphasis on outcome-based care, and the greater integration of pharmacotherapy with behavioral therapy. Key trends for the forecast period encompass the increasing uptake of combined behavioral and pharmacological treatments, a heightened focus on individualized addiction therapy programs, the expanding utilization of digital therapeutics and remote patient monitoring, the development of multidisciplinary treatment strategies, and a greater emphasis on prompt diagnosis and early intervention.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cannabis-use-disorder-global-market-report

Which Strong Drivers Are Impacting The Cannabis Use Disorder Market Growth?

The cannabis use disorder market is projected to expand due to the growing recognition and detection of cannabis addiction. This awareness and diagnosis process entails informing the general public, medical professionals, and affected individuals about the indicators, manifestations, and dangers associated with cannabis use disorder (CUD). The heightened awareness and diagnostic rates for cannabis addiction stem from various elements, including broader cannabis legalization and accessibility, alongside enhanced scientific and medical acknowledgment of the condition. Moreover, treatment for cannabis use disorder provides a structured method for handling withdrawal symptoms, alleviating cravings, and addressing underlying psychological components, thereby directly aiding in the diagnosis of cannabis addiction by offering clinical proof of dependency patterns, emphasizing the seriousness of the disorder, and directing suitable intervention based on a person’s particular requirements. For example, data from November 2024, released by The Office for Health Improvement and Disparities, a UK government body, indicated that the proportion of new individuals seeking help for cannabis-related issues stayed fairly consistent this year, showing a marginal increase of 0.5 percentage points, from 20.9% to 21.4%. In contrast, the count of new patients presenting with benzodiazepine-related difficulties increased from 3,620 in 2022–2023 to 3,872 in the current year. Consequently, the rising awareness and improved diagnosis of cannabis addiction are fueling the expansion of the cannabis use disorder market.

What Are The Main Segments Within The Cannabis Use Disorder Market Segment Structure?

The cannabis use disorder market covered in this report is segmented –

1) By Treatment: Pharmacotherapy, Behavioral Therapies

2) By Route Of Administration: Oral, Transdermal, Inhalation, Sublingual

3) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers

Subsegments:

1) By Pharmacotherapy: Cannabinoid-Based Medications, Antidepressants, Anxiolytics (Non-Benzodiazepine), Antipsychotics

2) By Behavioral Therapies: Cognitive Behavioral Therapy (CBT), Contingency Management, Motivational Enhancement Therapy (MET), 12-Step Facilitation Therapy

Which Trends Are Contributing To Changes In The Cannabis Use Disorder Market?

Leading firms within the cannabis use disorder (CUD) market are concentrating their efforts on creating sophisticated solutions, including digital therapeutics and technologically driven behavioral intervention platforms. These innovations aim to assist individuals in moderating or ceasing problematic cannabis consumption through structured guidance, tailored care approaches, and continuous assistance. Specifically, digital therapeutics for CUD treatment encompass clinically proven, technology-powered programs that administer behavioral therapies, monitor user progress, and offer remote connections to licensed clinicians, thereby enhancing treatment adherence and outcomes for sustained recovery. An illustrative example occurred in April 2024, when Pelago, a U.S.-based virtual clinic focused on substance use management, launched a new cannabis use disorder (CUD) treatment initiative. This program seeks to support the expanding population affected by CUD, which is estimated to include almost 18 million adults across the U.S. Pelago’s offering includes educational content on cannabis use and employs evidence-based treatments like cognitive behavioral therapy and motivational enhancement therapy, additionally providing help for adolescents aged 15-17 with treatment objectives centered on abstinence.

Who Are The Companies Participating In The Cannabis Use Disorder Market?

Major companies operating in the cannabis use disorder market are Lyra Health Inc., Pyramid Healthcare Inc., Hazelden Betty Ford Foundation, Charlie Health, Caron Treatment Center, Promises Behavioral Health, Sierra Tucson, Samarpan, Affect Therapeutics Inc., Cadabam’s Rehabilitation Center, Aelis Farma, Skywood Recovery, Pelago, PleoPharma Inc., Abhasa, Marijuana Anonymous, Northpoint Colorado, Sukoon Health, Granite Mountain Behavioral Healthcare, GreeneStone

Get The Full Cannabis Use Disorder Market Report:

https://www.thebusinessresearchcompany.com/report/cannabis-use-disorder-global-market-report

Which Region Is The Top Contributor To The Cannabis Use Disorder Market By Share?

North America was the largest region in the cannabis use disorder market in 2025. The regions covered in the cannabis use disorder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cannabis Use Disorder Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cannabis-use-disorder-global-market-report

Browse Through More Reports Similar to the Global Cannabis Use Disorder Market 2026, By The Business Research Company

Cannabis Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-testing-global-market-report

Cannabinoids Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabinoids-global-market-report

Medical Marijuana Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-marijuana-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795